Pfizer confirms COVID pill’s results, potency versus omicron
Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant.
FDA panel backs first-of-a-kind COVID-19 pill from Merck
A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.
Merck COVID pill effective, experts will review safety, FDA says
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.
New hurdle for COVID-19 home testing – the holiday season
Millions more home tests for COVID-19 are hitting store shelves, but will there be enough for Americans hoping to screen themselves before holiday gatherings?
Pfizer asks US officials to OK promising COVID-19 pill
Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
Regulators lay out plan for over-the-counter hearing aids
Health regulators on Tuesday unveiled their proposal to allow Americans to buy hearing aids without a prescription, a long-awaited move intended to make the devices more accessible to millions of people with hearing problems.
New FDA chief can’t come soon enough for beleaguered agency
Straining under a pandemic workload and battered by a string of public controversies, one of the leading agencies in the government's fight against COVID-19 is finally on the verge of getting a new commissioner.
J&J seeks US clearance for COVID-19 vaccine booster doses
Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
Biden bets on rapid COVID tests but they can be hard to find
President Joe Biden is betting on millions more rapid, at-home tests to help curb the latest deadly wave of the COVID-19 pandemic, which is overloading hospitals and threatening to shutter classrooms around the country.
FDA delays decision on e-cigarettes from vaping giant Juul
Federal health officials on Thursday delayed a high-stakes decision on whether to permit bestselling vaping brand Juul to stay on the market, while ordering thousands of other electronic cigarettes off store shelves.
